Hygeia Healthcare Holdings Co Ltd (6078) Fair Value & Analysis
Healthcare · HK · Market cap HK$5.7B
Fair value as of: Aug 13, 2026
From 23 valuation models · updated 3 days ago
Fair value updated Aug 13, 2026, revised from HK$8.83 to HK$8.84 (+0.1%) since Aug 6, 2026. Share price −5.1% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits above even our optimistic bull case (HK$8.84). The favourable scenario is already priced in.
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range HK$8.16 – HK$107.73 · fair‑value band HK$6.84 – HK$8.84 · the HK$9.75 price screens above the HK$8.84 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Hygeia Healthcare Holdings Co Ltd (6078) currently trades at HK$9.75, while our model-based Fair Value estimate is HK$8.84, implying the stock looks roughly 9.3% fairly valued today. The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Hygeia Healthcare Holdings Co Ltd generated revenue of HK$4.0B at a net margin of 4.1%. Revenue declined 2.2% year over year. It earns a return on equity of 2.4%. Net debt stands at HK$2.0B. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$6.84 (bear case) to HK$8.84 (bull case); at HK$9.75, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat. The share trades about 47% below its 52-week high and 20% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -9%, 6078 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: DCF Models (HK$15.36) versus Economic Profit (HK$1.44). Highest evidence: Growth DCF (80).
Notify me when 6078 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 49 · Market factors (momentum, volatility) 31
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Hygeia Healthcare Holdings Co., Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that provides oncology healthcare services, such as radiotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation.
Full company description
Hygeia Healthcare Holdings Co., Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that provides oncology healthcare services, such as radiotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. It also provides radiotherapy services to third-party hospitals, including radiotherapy center consulting services, licensing of radiotherapy equipment for use in the radiotherapy centers, and maintenance and technical support services for radiotherapy equipment. In addition, the company provides management services to private not-for-profit hospitals, as well as supply chain services; sells pharmaceutical, medical consumables, and medical equipment to third parties; and produces proprietary SRT equipment. The company was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Hygeia Healthcare Holdings Co Ltd reported revenue of HK$4.0B in FY2025 versus HK$2.3B in FY2021, a compound +14.7%/yr. Reported net income was HK$165M in FY2025, compounding −21.9%/yr from FY2021.
Watch 6078: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 266 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare Hygeia Healthcare Holdings Co Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Hygeia Healthcare Holdings Co Ltd (6078) overvalued or undervalued?
What is the fair value of 6078?
What is the quality score of 6078?
What is the revenue of Hygeia Healthcare Holdings Co Ltd (6078)?
What is the net profit margin of 6078?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Hygeia Healthcare Holdings Co Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.